Veterinary Medicines

AVINEW

Not authorised
  • Newcastle disease virus, strain VG/GA, Live
Download as PDF

Product identification

Medicine name:
AVINEW
Avinew Lyofilisaat voor suspensie voor oculonasaal gebruik/voor gebruik in drinkwater
Avinew Lyophilisat pour suspension oculonasale/administration dans l'eau de boisson
Avinew Lyophilisat zur Herstellung einer Suspension zur oculonasalen Anwendung/zum Eingeben über das Trinkwasser
Active substance:
  • Newcastle disease virus, strain VG/GA, Live
Target species:
  • Chicken (layer hen)
  • Chicken (for reproduction)
  • Chicken (broiler)
Route of administration:
  • Ocular use
  • Oral use
  • Oculonasal use

Product details

Active substance and strength:
  • Newcastle disease virus, strain VG/GA, Live
    5.50
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension
Withdrawal period by route of administration:
  • Ocular use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
  • Oral use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
  • Oculonasal use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Belgium
Package description:
  • Box of one 2,000-dose bottle
  • Box of ten 1,000-dose bottles
  • Box of ten 2,000-dose bottles
  • Box of one 1,000-dose bottle

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V235514
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0123/001

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download